SG Americas Securities LLC purchased a new position in shares of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Free Report) in the 4th quarter, Holdings Channel.com reports. The fund purchased 69,625 ...

Check the time stamp on this data. Updated AI-Generated Signals for Iovance Biotherapeutics Inc. (IOVA) available here: IOVA.

In a report released today, Joseph Catanzaro from Piper Sandler maintained a Hold rating on Iovance Biotherapeutics (IOVA – Research Report), ...

Truist Securities confirmed its positive stance on Iovance Biotherapeutics (NASDAQ:IOVA) shares, maintaining a Buy rating and a price target of $25.00. With the stock currently trading at $6.07, this ...

In a report released today, Asthika Goonewardene from Truist Financial assigned a Buy rating to Iovance Biotherapeutics (IOVA – Research ...

It was about a year ago that shares of Iovance Biotherapeutics (NASDAQ: IOVA) began to take off. Could this be a great buying ...

Iovance Biotherapeutics (NASDAQ: IOVA), a small-cap biotech company, has an innovative approach to treating cancer that ...

If you're looking for an under-the-radar stock that could deliver enormous gains in a defined time frame, the ...

A Bay Area biotech is suing its insurance company to cover costs associated with patients allegedly injured during clinical ...

Technical analysis for Iovance Biotherapeutics Inc. IOVA including support levels resistance levels and stop losses for IOVA ...